HIV-1 genetic variants and primary drug resistance among recently infected individuals in Krasnodar Region, 2014–2022
Journal of microbiology, epidemiology and immunobiology · 18.06.2026 · 103 (5) · 585-596
DOI: 10.36233/0372-9311-810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of microbiology, epidemiology and immunobiology, online erschienen am 18.06.2026. Verfasst von A. V. Shlykova und 9 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
HIV-1 drug resistance (DR) is a significant and ongoing public health problem at the present time. As access to antiretroviral therapy increases, the risk of developing transmitted DR also increases. DR testing within the first year after infection improve the accuracy of detecting drug-resistant HIV-1 variants. The aim of this study was to analyze HIV-1 genetic variants and transmitted DR among individuals with recent infection identified in the Krasnodar Region. Materials and methods. A sample of 295 patients was recruited; recent infection was confirmed with epidemiological information, laboratory evidence of seroconversion, and/or testing results using a specialized kit for estimating the approximate timing of HIV-1 infection. Nucleotide sequences of the HIV-1 genome fragment (positions 2253–3369) were obtained using Sanger sequencing, the virus genetic variant was determined, and DR analysis was performed.
Results
Sub-subtype A6 was dominant in the study sample (78.64%), with an increase in its proportion over time: 71.05% in 2014–2018 vs 83.44% in 2019–2022 (p = 0.0116). Surveillance DR mutations (SDRM) were detected in 29 patients (9.83%), with an upward trend: from 5.26% in 2014–2018 to 12.71% in 2019–2022 (p = 0.0365). Drug-resistant HIV-1 variants were detected in 49 patients (16.61%). DR to non-nucleoside reverse transcriptase inhibitors was the most frequently recorded (13.22%), while DR to protease inhibitors (2.03%) and nucleoside reverse transcriptase inhibitors (1.02%) was less common.
Conclusion
The results indicate a moderate level of detection of HIV-1 transmitted DR among individuals with recent infection, which requires the adoption of appropriate measures within the framework of surveillance of drug-resistant HIV-1 variants.
Zitieren
APA
Shlykova, A. V., Syrkina, A. V., Kirichenko, A. A., Lapovok, I. A., Shemshura, A. B., Lebedev, P. V., Nestyak, L. V., Kulagin, V. V., Kireev, D. E., & Akimkin, V. G. (2026). HIV-1 genetic variants and primary drug resistance among recently infected individuals in Krasnodar Region, 2014–2022. Journal of microbiology, epidemiology and immunobiology, 103(5), 585-596. https://doi.org/10.36233/0372-9311-810
Vancouver
Shlykova AV, Syrkina AV, Kirichenko AA, Lapovok IA, Shemshura AB, Lebedev PV, et al. HIV-1 genetic variants and primary drug resistance among recently infected individuals in Krasnodar Region, 2014–2022. Journal of microbiology, epidemiology and immunobiology. 2026;103(5):585-596. doi:10.36233/0372-9311-810
BibTeX
@article{Shlykova2026,
author = {Shlykova, A. V. and Syrkina, A. V. and Kirichenko, A. A. and Lapovok, I. A. and Shemshura, A. B. and Lebedev, P. V. and Nestyak, L. V. and Kulagin, V. V. and Kireev, D. E. and Akimkin, V. G.},
title = {HIV-1 genetic variants and primary drug resistance among recently infected individuals in Krasnodar Region, 2014–2022},
journal = {Journal of microbiology, epidemiology and immunobiology},
year = {2026},
volume = {103},
number = {5},
pages = {585--596},
doi = {10.36233/0372-9311-810}
}
EUVIMED